Nuvation Bio NUVB Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $62.9M+699% | $7.87M— | $0— | —— | ||
| $115.11M+16.1% | $99.12M+39.0% | $71.29M-18.8% | $87.82M+27.2% | ||
| $151.56M+119% | $69.23M+143% | $28.53M— | —— | ||
| $278.06M-53.7% | $600.5M+502% | $99.82M-16.6% | $119.74M+28.3% | ||
| $13.68M+3,912% | $341K— | $0— | —— | ||
| —— | $24.69M+2.8% | $24.02M+54.6% | $15.54M+140% | ||
| -$204.63M+64.0% | -$567.94M-649% | -$75.8M+27.3% | -$104.2M-20.0% | ||
| $0— | $0— | $0— | $0— | ||
| -$204.63M+64.0% | -$567.94M-649% | -$75.8M+27.3% | -$104.2M-20.0% | ||
| -325.3%+6,888pp | -7,213.8%— | —— | —— | ||
| -$211.33M+64.3% | -$591.94M-494% | -$99.6M+16.7% | -$119.54M-28.3% | ||
| -336%+7,183pp | -7,518.7%— | —— | —— | ||
| -$213.06M+64.0% | -$592.63M-494% | -$99.82M+16.6% | -$119.74M-28.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Nuvation Bio's revenue?
- Nuvation Bio (NUVB) generated $143.0M in revenue over the trailing twelve months, up 1205.5% year over year.
- Is Nuvation Bio profitable?
- Nuvation Bio is not currently profitable: it reported a net loss of $146.0M over the trailing twelve months, a -102.1% net margin.
- What are Nuvation Bio's profit margins?
- Gross margin is 54.3% and operating margin is -105.0%, with a -102.1% net margin.
- What is Nuvation Bio's earnings per share?
- Nuvation Bio's diluted EPS over the trailing twelve months is $-0.43.
- Where does Nuvation Bio's income statement data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
